Sickness and disability is a key economic policy concern for many OECD countries. Medical conditions, or problems labelled as such by societies and policy systems, are proving an increasing obstacle to raising labour force participation and keeping public expenditure under control. More and more people of working age rely on sickness and disability benefits as their main source of income, and the employment rates of those reporting
This report is on how to support governments and industry in building a sustainable bio-based economy. The OECD Task Force on Industrial Biotechnology is considering the development of a set of recommendations in the area of Environmental and Economic Sustainability.
Sickness and disability policy reform has been a priority for OECD countries wanting to improve employment and social outcomes in this domain. The recent recession and corresponding fall in labour demand is expected to hit marginalised workers, including workers with health problems or disability, harder than the broader working-age population. There is a pressing need for policy makers to address the recent “medicalisation” of labour
The main objectives of the panel were to launch the report from Montreal Workshop entitled “Towards the Development of OECD Best Practices for Assessing the Sustainability of Bio-based Products” and to communicate its main conclusions.
Health services account for a large and increasing share of production and expenditure in OECD countries but there are also noticeable differences between countries in expenditure per capita. Whether such differences are due to more services consumed in some countries than in others or whether they reflect differences in the price of services is a question of significant policy relevance. Yet, cross-country comparisons of the price of
This report presents an analysis of OECD countries’ efforts toimplement information and communication technologies (ICTs) in healthcare systems.
The key goal of the current work is to identify further means (e.g. international guidelines, policy recommendations) to implement the 2004 OECD Science and Technology Ministers mandate on “Biotechnology for Sustainable Growth and Development” .
The ratio of health expenditure to GDP, which in macroeconomic terms is an indicator which summarises the financing needs of a national health system, is likely to rise in countries for which the GDP falls. This paper reviews the possible implications of the recessions for this ratio.
The OECD Factbook is the best-selling, innovative title from the OECD. It provides a global overview of today’s major economic, social and environmental indicators, presenting them clearly and concisely, and in a range of user-friendly formats.
This July 2009 symposium brought together the different communities – scientific, engineering, policy, public and legal – involved in synthetic biology and explored the opportunities and challenges posed by this emerging field.